The trial also tracked major adverse cardiovascular events (MACE): hazard ratios of 1.12 (3-component composite) and 0.82 (5-component composite), neither statistically significant
Semaglutide is a medication that mimics a natural hormone called GLP-1 (glucagon-like peptide-1) in the body to regulate appetite, increase insulin and slow down the digestion process
[3] Teichman S, et al
In the later period, new users in both SGLT2i and GLP-1 RA cohorts were older, use of medications for type 2 diabetes was less intensive, and metabolic control was better, and although more patients had renal function assessed, patients had more severe CKD (stage 3: 44.052.1% vs
However, it can sometimes be confused with pathological conditions such as post-inflammatory hyperpigmentation, which may arise from external factors like sun exposure, trauma, or allergic reactions